Cleveland Clinic researchers have discovered that just about two-thirds of sufferers with HER2-positive metastatic breast most cancers didn't obtain the guideline-recommended normal...
Researchers have introduced data revealing how sufferers with metastatic breast most cancers develop resistance to the therapy Enhertu (trastuzumab deruxtecan, T-DXd) in...
This years 2026 ASCO Gastrointestinal Cancers Symposium was full of practice-shaping knowledge throughout colorectal and higher gastrointestinal malignancies, in line with Dr....
